Table 1.
Source | n | Gender (male/female) | Onset (spinal/bulbar) | Age (years) | Symptom duration (months) | Baseline weight (kg) | Baseline ALSFRS (score) | Baseline ALSFRS decline rate (score/month) |
---|---|---|---|---|---|---|---|---|
PRO-ACT | 3,971 | 2,485/1,486 | 3,117/854 | (18:81) | (0.5:140.4) | (30:148.6) | (7:40) | (6.09:0) |
Trophos | 431 | 277/154 | 346/85 | (26:79) | (5:38) | (41:130) | (16:40) | (2.67:0) |
Exonhit | 172 | 118/54 | 129/43 | (26.3:77.9) | (5:58) | (45:112) | (10:39) | (3.14:0.05) |
Real world | 646 | 345/301 | 458/188 | (26.3:92.2) | (0:228.5) | (40:140) | (3.5:40) | (4.16:0) |
Overall | 5,220 | 3,225/1,995 | 4,050/1,170 | (18:92.2) | (0:228.5) | (30:148.6) | (3.5:40) | (6.09:0) |
Numerical predictors are described using mean ± standard deviation (range).